Repligen (RGEN) Current Deferred Revenue (2011 - 2026)

Repligen (RGEN) has 15 years of Current Deferred Revenue data on file, last reported at $18.3 million in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $18.3 million, down 13.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.3 million (down 13.68% YoY), and the FY2025 annual result was $14.6 million, up 10.31% from the prior year.
• Current Deferred Revenue grew to $18.3 million in Q1 2026 per RGEN's latest filing, from $14.6 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $31.6 million in Q2 2023 and troughed at $13.2 million in Q4 2024.
• A 5-year average of $20.1 million and a median of $19.3 million in 2022 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue surged 54.95% in 2023, then sank 55.64% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $19.3 million in 2022, then decreased by 11.49% to $17.1 million in 2023, then declined by 22.41% to $13.2 million in 2024, then climbed by 10.31% to $14.6 million in 2025, then gained by 25.32% to $18.3 million in 2026.
• Business Quant data shows RGEN's Current Deferred Revenue at $18.3 million in Q1 2026, $14.6 million in Q4 2025, and $15.7 million in Q3 2025.